Internal regulations of the GHEVI+ workgroup


Organization of the GHEVI+ workgroup

-          Coordinator

-          Secretary

-          Steering committee (maximum 8 members).

-          SEFH Governance Board representative

-          Associate members supporting the workgroup’s activity.  

Functions of the GHEVI+ workgroup members
1. Coordinator:

-    To manage workgroup activities.

-    To coordinate the work of the workgroup with that of other workgroups.

-    To interact with SEFH’s Governance Board and with SEFH’s workgroup coordinator.

-    To define, together with the members of the workgroup, the goals to be pursued by the workgroup as well as the tasks to be completed and the workplan to be followed.

-    To prepare, together with the Secretary, a report of the workgroup’s annual activities, which should be sent to SEFH’s Technical Secretariat.

-    To advise SEFH on all matters relating to liver diseases.

-    To coordinate, together with the HIV workgroup, the annual conference on pharmaceutical care of patients with viral conditions.

-    To coordinate activities related to SEFH’s annual congresses.

-    To ensure proper maintenance of the workgroup’s website.

2.  Secretary:

-   To prepare, together with the coordinator, a report on the workgroup’s activities.

-   To convene and coordinate the workgroup’s meetings.

-   To interact with SEFH’s workgroup coordinator and SEFH’s technical secretariat.

-   To prepare the minutes of the workgroup’s meetings and send them to SEFH’s technical secretariat.

-   To ensure proper maintenance of the workgroup’s website

3.   Comité Coordinador:

-   To ensure that pharmacy departments contribute as much information as possible for the benefit of SEFH members.

-   To ensure proper management of the workgroup’s website.

-   To disseminate information on meetings, congresses, journals or websites that may be of interest to workgroup members.

-   To analyze workgroup membership applications.

-   To collaborate in the review of abstract submitted to SEFH’s annual congresses when they deal with aspects related to viral liver disease.

-   To participate in the activities of SEFH’s annual congresses (minimum participation: 30% of members).

Renewal of workgroup membership:

To maximize continuity and participation in the workgroup, membership will be renewed as follows:

-   The coordinator and secretary positions shall be renewed at SEFH’s annual congresses. Candidates for workgroup secretary must submit their candidacy up to one month from the annual congress. Should no candidates stand for election, a public call will be published in SEFH’s mailing list, which shall close 15 days before the congress.

After the first year of service, the secretary shall become the workgroup’s coordinator and a new secretary shall be elected.

The proceedings followed to elect the workgroup’s coordinator and secretary shall be recorded in a minutes’ book.

If no voluntary candidacy is submitted from any workgroup member of through SEFH’s mailing list, the coordinator’s and secretary’s term of office shall be extended one more year. The maximum term of office for these two positions shall be four years.

-   The membership of the steering committee shall be renewed annually after SEFH’s annual congress. Outgoing coordinators shall join the steering committee until the latter reaches 8 members. When this number is reached, the most senior steering committee member shall join the group that supports the activities of the workgroup.

Admission of new members to the GHEVI+ workgroup:

SEFH members may apply for GHEVI+ workgroup membership by sending an email to This email address is being protected from spambots. You need JavaScript enabled to view it.. Emails will be reviewed by the workgroup’s coordinator and secretary.

Applicants must be SEFH members and must be professionally involved in the pharmaceutical care of patients with viral liver conditions.

Exclusion of members from the GHEVI+ workgroup:

Members may be excluded from the workgroup when they fail to not perform the tasks assigned to them or when conflicts of interest are identified with other workgroups or with the pharmaceutical industry.

Exclusions must be approved by all workgroup members and be reflected in the minutes book.

Dissolution of the workgroup:

The workgroup may be dissolved when one of the following situations occurs:

-   All the goals proposed have been achieved and all tasks foreseen have been performed.

-   The workgroup has not conducted any activities for two consecutive years.

-   The initially proposed goals have ceased to be relevant.

-   The workgroup has infringed SEFH’s workgroup operational regulations.

For the workgroup to be dissolved, a written application must be sent to SEFH by the workgroup’s representative to SEFH’s Governance Board or my any member thereof, stating the reasons for the request.

Organization of the workgroup’s activities:

Every year, the coordinator and the secretary shall submit an economic and activity report to SEFH’s workgroup coordinator.

The report must include the following information:

  • Workgroup’s organizational structure
  • Current situation
  • Goals for the next year
  • Number of meetings held
  • Educational and research activities performed, publications, postings on SEFH’s website and conferences organized.

Every year, following SEFH’s annual congress, a breakdown of the workgroup’s goals and activities for the next year must be prepared, as well as a calendar of the work to be performed and the meetings to be held. This information as well as that corresponding to the workgroup’s finances must be conveyed to all workgroup members.

At least three workgroup meetings will be held every year:

-    The first one shall be a face-to-face meeting held at the end of January or the beginning of February.

-    The second one, also face-to-face, will be held during the annual conference on the pharmaceutical care of patients with viral conditions (April-May).

-    The third one will be held after the summer (September/October) and may be face-to-face or remote, depending on the topics to be discussed..